Related Experiment Video
Updated: May 30, 2026

Inducible and Reversible Dominant-negative (DN) Protein Inhibition
Published on: January 7, 2019
Kinetic recognition of the retinoblastoma tumor suppressor by a specific protein target
Lucía B Chemes1, Ignacio E Sánchez, Gonzalo de Prat-Gay
1Protein Structure-Function and Engineering Laboratory, Fundación Instituto Leloir and IIBBA-CONICET, Avenida Patricias Argentinas 435, 1405 Buenos Aires, Argentina.
Abstract:
The retinoblastoma tumor suppressor (Rb) plays a key role in cell cycle control and is linked to various types of human cancer. Rb binds to the LxCxE motif, present in a number of cellular and viral proteins such as AdE1A, SV40 large T-antigen and human papillomavirus (HPV) E7, all instrumental in revealing fundamental mechanisms of tumor suppression, cell cycle control and gene expression. A detailed kinetic study of RbAB binding to the HPV E7 oncoprotein shows that an LxCxE-containing E7 fragment binds through a fast two-state reaction strongly favored by electrostatic interactions. Conversely, full-length E7 binds through a multistep process involving a pre-equilibrium between E7 conformers, a fast electrostatically driven association step guided by the LxCxE motif and a slow conformational rearrangement. This kinetic complexity arises from the conformational plasticity and intrinsically disordered nature of E7 and from multiple interaction surfaces present in both proteins. Affinity differences between E7N domains from high- and low-risk types are explained by their dissociation rates. In fact, since Rb is at the center of a large protein interaction network, fast and tight recognition provides an advantage for disruption by the viral proteins, where the balance of physiological and pathological interactions is dictated by kinetic ligand competition. The localization of the LxCxE motif within an intrinsically disordered domain provides the fast, diffusion-controlled interaction that allows viral proteins to outcompete physiological targets. We describe the interaction mechanism of Rb with a protein ligand, at the same time an LxCxE-containing model target, and a paradigmatic intrinsically disordered viral oncoprotein.
Insights
The retinoblastoma tumor suppressor (Rb) protein interacts with viral oncoproteins like HPV E7. This study reveals the complex kinetics of Rb binding to E7, crucial for understanding cancer mechanisms.
Area of Science:
- Molecular Biology
- Virology
- Biochemistry
Background:
- The retinoblastoma tumor suppressor (Rb) protein is critical for cell cycle regulation and is implicated in human cancers.
- Rb interacts with viral oncoproteins containing the LxCxE motif, such as HPV E7, which are key to understanding tumor suppression and gene expression.
Purpose of the Study:
- To investigate the detailed kinetic mechanisms of retinoblastoma tumor suppressor (Rb) binding to the human papillomavirus (HPV) E7 oncoprotein.
- To elucidate how the intrinsically disordered nature of E7 and multiple interaction surfaces contribute to the binding kinetics and affinity.
Main Methods:
- Detailed kinetic analysis of RbAB binding to HPV E7 oncoprotein fragments and full-length E7.
- Characterization of binding reactions, including association and dissociation rates, and the role of electrostatic interactions and conformational changes.
Main Results:
- An LxCxE-containing E7 fragment binds Rb via a fast, two-state reaction favored by electrostatics.
- Full-length E7 exhibits complex, multi-step binding involving conformational changes and a slow rearrangement, influenced by E7's disordered nature.
- Differences in Rb-E7 affinity between high- and low-risk HPV types correlate with dissociation rates.
Conclusions:
- The kinetic complexity of Rb-E7 interaction arises from protein plasticity and multiple interaction sites.
- Fast recognition of the LxCxE motif in intrinsically disordered regions allows viral proteins to outcompete physiological targets.
- Understanding these binding dynamics is essential for comprehending viral oncoprotein function and developing therapeutic strategies.
More Related Videos
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Receptor Tyrosine Kinases
Negative Regulator Molecules
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Inhibition of Cdk Activity
